Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation

Kevin R. Krull, Nan Zhang, Aimee Santucci, Deo Kumar Srivastava, Matthew J. Krasin, Larry E. Kun, Ching Hon Pui, Leslie L. Robison, Melissa M. Hudson, Gregory T. Armstrong

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Survivors of childhood acute lymphoblastic leukemia (ALL) treated with cranial radiation therapy (CRT) are at risk for cognitive impairment, although whether impairment progresses with age into adulthood is unknown. We report change in intelligence for 102 adult survivors of childhood ALL (age range, 26.6-54.7 years) during a median interval of 28.5 years. Survivors demonstrated lower Performance intelligence (mean, 95.3; standard deviation, 16.5; P 5 .005) but not Verbal IQ (mean, 97.4; standard deviation, 15.44; P 5 .09) at initial testing. Verbal intelligence declined an average of 10.3 points (P < .0001) during the follow-up interval with no decline in Performance intelligence. Decline was associated with current attention problems (P 5 .002) but not gender, CRT dose, age at CRT exposure, or years between testing. Results suggest long-term survivors of childhood ALL treated with CRT are at risk for progressive decline in verbal intellect, which may be driven by attention deficits. This trial was registered at clinicaltrials.gov as no. NCT00760656.

Original languageEnglish (US)
Pages (from-to)550-553
Number of pages4
JournalBlood
Volume122
Issue number4
DOIs
StatePublished - Jul 25 2013

Fingerprint

Radiotherapy
Intelligence
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Survivors
Radiation
Testing
Dosimetry

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. / Krull, Kevin R.; Zhang, Nan; Santucci, Aimee; Srivastava, Deo Kumar; Krasin, Matthew J.; Kun, Larry E.; Pui, Ching Hon; Robison, Leslie L.; Hudson, Melissa M.; Armstrong, Gregory T.

In: Blood, Vol. 122, No. 4, 25.07.2013, p. 550-553.

Research output: Contribution to journalArticle

Krull, KR, Zhang, N, Santucci, A, Srivastava, DK, Krasin, MJ, Kun, LE, Pui, CH, Robison, LL, Hudson, MM & Armstrong, GT 2013, 'Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation', Blood, vol. 122, no. 4, pp. 550-553. https://doi.org/10.1182/blood-2013-03-487744
Krull, Kevin R. ; Zhang, Nan ; Santucci, Aimee ; Srivastava, Deo Kumar ; Krasin, Matthew J. ; Kun, Larry E. ; Pui, Ching Hon ; Robison, Leslie L. ; Hudson, Melissa M. ; Armstrong, Gregory T. / Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. In: Blood. 2013 ; Vol. 122, No. 4. pp. 550-553.
@article{a6a002b1f91843be81704d2b1aedc27c,
title = "Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation",
abstract = "Survivors of childhood acute lymphoblastic leukemia (ALL) treated with cranial radiation therapy (CRT) are at risk for cognitive impairment, although whether impairment progresses with age into adulthood is unknown. We report change in intelligence for 102 adult survivors of childhood ALL (age range, 26.6-54.7 years) during a median interval of 28.5 years. Survivors demonstrated lower Performance intelligence (mean, 95.3; standard deviation, 16.5; P 5 .005) but not Verbal IQ (mean, 97.4; standard deviation, 15.44; P 5 .09) at initial testing. Verbal intelligence declined an average of 10.3 points (P < .0001) during the follow-up interval with no decline in Performance intelligence. Decline was associated with current attention problems (P 5 .002) but not gender, CRT dose, age at CRT exposure, or years between testing. Results suggest long-term survivors of childhood ALL treated with CRT are at risk for progressive decline in verbal intellect, which may be driven by attention deficits. This trial was registered at clinicaltrials.gov as no. NCT00760656.",
author = "Krull, {Kevin R.} and Nan Zhang and Aimee Santucci and Srivastava, {Deo Kumar} and Krasin, {Matthew J.} and Kun, {Larry E.} and Pui, {Ching Hon} and Robison, {Leslie L.} and Hudson, {Melissa M.} and Armstrong, {Gregory T.}",
year = "2013",
month = "7",
day = "25",
doi = "10.1182/blood-2013-03-487744",
language = "English (US)",
volume = "122",
pages = "550--553",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation

AU - Krull, Kevin R.

AU - Zhang, Nan

AU - Santucci, Aimee

AU - Srivastava, Deo Kumar

AU - Krasin, Matthew J.

AU - Kun, Larry E.

AU - Pui, Ching Hon

AU - Robison, Leslie L.

AU - Hudson, Melissa M.

AU - Armstrong, Gregory T.

PY - 2013/7/25

Y1 - 2013/7/25

N2 - Survivors of childhood acute lymphoblastic leukemia (ALL) treated with cranial radiation therapy (CRT) are at risk for cognitive impairment, although whether impairment progresses with age into adulthood is unknown. We report change in intelligence for 102 adult survivors of childhood ALL (age range, 26.6-54.7 years) during a median interval of 28.5 years. Survivors demonstrated lower Performance intelligence (mean, 95.3; standard deviation, 16.5; P 5 .005) but not Verbal IQ (mean, 97.4; standard deviation, 15.44; P 5 .09) at initial testing. Verbal intelligence declined an average of 10.3 points (P < .0001) during the follow-up interval with no decline in Performance intelligence. Decline was associated with current attention problems (P 5 .002) but not gender, CRT dose, age at CRT exposure, or years between testing. Results suggest long-term survivors of childhood ALL treated with CRT are at risk for progressive decline in verbal intellect, which may be driven by attention deficits. This trial was registered at clinicaltrials.gov as no. NCT00760656.

AB - Survivors of childhood acute lymphoblastic leukemia (ALL) treated with cranial radiation therapy (CRT) are at risk for cognitive impairment, although whether impairment progresses with age into adulthood is unknown. We report change in intelligence for 102 adult survivors of childhood ALL (age range, 26.6-54.7 years) during a median interval of 28.5 years. Survivors demonstrated lower Performance intelligence (mean, 95.3; standard deviation, 16.5; P 5 .005) but not Verbal IQ (mean, 97.4; standard deviation, 15.44; P 5 .09) at initial testing. Verbal intelligence declined an average of 10.3 points (P < .0001) during the follow-up interval with no decline in Performance intelligence. Decline was associated with current attention problems (P 5 .002) but not gender, CRT dose, age at CRT exposure, or years between testing. Results suggest long-term survivors of childhood ALL treated with CRT are at risk for progressive decline in verbal intellect, which may be driven by attention deficits. This trial was registered at clinicaltrials.gov as no. NCT00760656.

UR - http://www.scopus.com/inward/record.url?scp=84886884561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886884561&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-03-487744

DO - 10.1182/blood-2013-03-487744

M3 - Article

VL - 122

SP - 550

EP - 553

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -